Clinicians can preliminarily judge whether patients are infected and whether the infections are caused by G- or G+ bacteria; according to the cytokines, they can adjust antibiotic treatments in a timely manner and evaluate the effect of anti-infection treatment through dynamic monitoring of IL-6 and IL-10 changes. This evidence concerns the gene IL6 and infection.